Euphausia superba
Euphausia superba has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jul 8, 2026: “Efficacy and Safety of Antarctic Krill Oil Extract (FJH-KO) on Platelet Aggregation and Arterial Stiffness in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial”.
1 paper studies it3 findingsUpdated
“Notably, the high-dose group demonstrated a significant reduction in ba-PWV compared to the placebo group (p = 0.006), reflecting reduced arterial stiffness.”
- 1 lab in 1 country
- Human trial1
What did studies of Euphausia superba find?
3Studies of Euphausia superba measured 3 outcomes; the most studied are SELP (1 study), platelet aggregation time (1) and brachial-ankle pulse wave velocity (1).
SELP
downin humans1
1 study
SELP
downin humans1
Euphausia superba decreases SELP in humans.
“High-dose FJH-KO was also associated with a within-group reduction in P-selectin”
Human trialwithin-group reductionFJH-KOplasma-serum750 mg/day12 weeks
Journal of dietary supplements
Platelet aggregation time
upin humans1
1 study
Platelet aggregation time
upin humans1
Euphausia superba increases platelet aggregation time in humans.
“FJH-KO supplementation showed significant between-group differences in platelet aggregation time and ba-PWV.”
Human trialbetween-group differenceFJH-KO12 weeksn = 120
Journal of dietary supplements
Brachial-ankle pulse wave velocity
downin humans1
1 study
Brachial-ankle pulse wave velocity
downin humans1
Euphausia superba decreases brachial-ankle pulse wave velocity in humans.
“Notably, the high-dose group demonstrated a significant reduction in ba-PWV compared to the placebo group (p = 0.006), reflecting reduced arterial stiffness.”
Human trialcompared to placeboFJH-KO750 mg/day12 weeksn = 120
Journal of dietary supplements